GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » PensionAndRetirementBenefit

Genexine (XKRX:095700) PensionAndRetirementBenefit : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine PensionAndRetirementBenefit?

Genexine's PensionAndRetirementBenefit for the quarter that ended in Mar. 2024 was ₩0 Mil.

Genexine's quarterly PensionAndRetirementBenefit declined from Sep. 2023 (₩541 Mil) to Dec. 2023 (₩0 Mil) but then stayed the same from Dec. 2023 (₩0 Mil) to Mar. 2024 (₩0 Mil).

Genexine's annual PensionAndRetirementBenefit declined from Dec. 2021 (₩554 Mil) to Dec. 2022 (₩82 Mil) and declined from Dec. 2022 (₩82 Mil) to Dec. 2023 (₩0 Mil).


Genexine PensionAndRetirementBenefit Historical Data

The historical data trend for Genexine's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine PensionAndRetirementBenefit Chart

Genexine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PensionAndRetirementBenefit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 924.37 899.27 554.15 81.92 -

Genexine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 450.99 381.07 540.92 - -

Genexine PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Genexine (XKRX:095700) Business Description

Industry
Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines